SC 13G Filing

Company

CytomX Therapeutics, Inc.

Filed

November 10, 2015

Accession Number

0000315066-15-003289

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →